Description

Sorafenib, sold under the brand name Nexavar, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.?W
Share ThisFacebookTwitterWhatsAppPinterestShare This

Reviews
Ratings

0.0

0 Product Ratings
5
0
4
0
3
0
2
0
1
0

Review this product

Share your thoughts with other customers

Write a review

Reviews

There are no reviews yet.